DirtyWorks said:
1. When riders were wearing heartrate monitors to bed so they didn't die in their sleep was theraputic levels of oxygen vector doping?
These were the crazy 80ies/90ies. If there was any UCI rule that made sense, it was the 50% rule. Just to save the riders' lifes.
EPO should be administered until the patient is @ ca. 40% HCT and is considered "safe" until at least 50% and if under constant monitoring even more. Remember that heavy smokers or heavy T-abusers (read: bodybuilders) or a combination of both approach 55+ or even 60% HCT frequently.
I would be more concerned about cell growth which according to studies appears to be dosage-independent. It sucks to be a Pro, just wait a few years until cancer kicks in across the board.
DirtyWorks said:
Hinault's rumored(?) ruined joints were the result of theraputic levels of steroids?
It was cortisone. Cortisone is really bad stuff, it killed my granny actually.
DirtyWorks said:
2. Let's argue for a minute you could verify who was taking what at what dosage, the point is the riders aren't recovering from an illness. Please don't use the Fuentes quote.
The most generally accessible document is obviously Voets book. But there are so many "training"-plans, you may want to search for yourself.
And then there is the small world of cycling, training partners and such. Somebody who knows somebody. Go riding in Italy, talk to the
dilletanti, I found them very chatty - at least in the early twothousands. But as I repeatedly stated: my country is really small as well. And I come from a town that is well known for a WADA accredited lab housed by a sports university and friends and training partners either study or teach there. Ask Clenberto which town that may be.
Edit: And furthermore there are pharmacokinetics. Educate yourself about the effects in relation to trigger values during testing. Btw the reason why I'm more concerned about amateur racers and weekend warriors that are rarely tested. Also learn about possible water retention, stiffness and all that stuff.